causal

Insulin prices driven by incentives beyond manufacturers and insurers

Drugs that are not especially innovative, including insulin, have seen rising prices driven by a tangle of incentives across the supply chain rather than simply by pharma companies or insurers alone.

causalpending

Speaker

D.A.

Evidence Quote

“drug prices have been driven up and up on drugs that are not that new or innovative, including drugs like insulin”

Source

Investing in Healthcare— Invest Like the Best
Created: 11/17/2026, 5:03:43 PM

Your notes

Loading notes...